Market Tracker

04/17 6:05pm ET

Actavis PLC (NYSE:ACT)

197.39
Data as of Apr 17
 -1.99 / -1.00%
Today’s Change
96.26
Today|||52-Week Range
230.77
+17.49%
Year-to-Date

Today’s Trading

Previous close199.38
Today’s open198.49
Day’s range-- - --
Volume1,522,676
Average volume (3 months)2,868,122
Market cap$33.4B
Dividend yield--
Data as of 04/17/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+36.02%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book3.50

Competitors

 Today’s
change
Today’s
% change
AGNAllergan Inc+2.46+1.87%
SHPGShire PLC+0.58+0.40%
ALXNAlexion Pharmaceutic...+0.75+0.50%
VRXValeant Pharmaceutic...+0.60+0.49%
Data as of 04/17/2014

Financials

Next reporting dateApril 30, 2014
EPS forecast (this quarter)$3.15
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Paul M. Bisaro
President-
Global Operations
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts